Sanjeev Miglani – Awinsa Life Sciences
View Detailed Executive Profile →Professional Overview
- Sanjeev Miglani is the Founder and Director of AWINSA Life Sciences, established in April 2018, focusing on advancing life science solutions.
- Prior to founding AWINSA Life Sciences, Miglani served as Vice President-PV and Clinical Safety North America & Global Medical Affairs at APCER Life Sciences from April 2016 to April 2018, overseeing critical pharmacovigilance practices.
- In a previous role at APCER Life Sciences, Miglani was the Head of Pharmacovigilance US Operations from October 2013 to April 2016, leading initiatives to ensure drug safety and compliance.
- Sanjeev Miglani held the position of Vice President Pharmacovigilance at Accenture from June 2012 to June 2013, contributing to the integration of safety measures in clinical research.
- As COO and Scientific Director at CIDP Biotech India Pvt. Ltd. from September 2010 to September 2012, Miglani played a vital role in operational management and scientific leadership.
- Previously, Miglani was the Director of Medical Affairs at CliniRx Research Pvt. Ltd. from July 2007 to September 2010, where important medical strategies were developed.
- Sanjeev Miglani also contributed as Senior Manager (Group Leader) for Medical Affairs and Clinical Research at Ranbaxy from March 2005 to July 2007, facilitating research and development efforts.
- Beginning a career in medicine, Miglani served as a Senior Resident in Cardiology at Sir Ganga Ram Hospital and underwent residency training at PGIMER Dr RML Hospital, acquiring extensive medical knowledge and experience.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| CIDP Biotech India Pvt. Ltd. | Chief Operating Officer and Scientific Director | Sep 2010 – Jun 2012 |
| APCER Life Sciences | Head Pharmacovigilance US Operations | Oct 2013 – Apr 2016 |
| Sir Ganga Ram Hospital | Senior Resident Cardiology | May 2003 – Jul 2003 |
| PGIMER Dr RML Hospital | MD (Internal Medicine) | May 2000 – Apr 2003 |
| Ranbaxy | Senior Manager (Group Leader) Medical Affairs and Clinical Research | Mar 2005 – Jul 2007 |
| Accenture | Vice President Pharmacovigilance | Jun 2012 – Oct 2013 |
| Maulana Azad Medical College New Delhi | MBBS | Jun 1993 – Dec 1998 |
| CliniRx Research Pvt. Ltd. | Director Medical Affairs | Jul 2007 – Sep 2010 |
| PGIMER Dr RML Hospital | Senior Resident Medicine and Cardiology | Jul 2003 – Mar 2005 |
| Lok Nayak Hospital | Junior Resident Burns and Plastic Surgery | Jan 1999 – Jan 1999 |
| APCER Life Sciences | Vice President-PV and Clinical Safety North America & Global Medical Affairs | Apr 2016 – Apr 2018 |
| AWINSA Life Sciences | Founder and Director | Apr 2018 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Awinsa Life Sciences corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Sanjeev Miglani's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Awinsa Life Sciences's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)